Adverse events following purified chick embryo cell rabies vaccine in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 2006–2016
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Adverse events following purified chick embryo cell rabies vaccine in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 2006–2016
  • Published Date:

    2019 May - Jun

  • Source:
    Travel Med Infect Dis. 29:80-81
  • Language:
    English
Filetype[PDF-289.06 KB]


Details:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 89.97 KB]
    Personal Author:
    Moro, Pedro L.; Perez-Vilar, Silvia; Lewis, Paige; Bryant-Genevier, Marthe; Kamiya, Hajime; Cano, Maria;
    Published Date:
    June 04 2018
    Source:
    Pediatrics. 142(1)
    Description:
    Objective:To assess the safety of currently licensed diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccines in the US using data from the Vaccine Adverse Event Reporting System (VAERS), a spontaneous reporting surveillance system.Meth...
    File Type:
    Filetype[PDF - 89.97 KB]
  2. Filetype[PDF - 265.31 KB]
    Published Date:
    February 28, 2019
    Source:
    MMWR. Morbidity and mortality weekly report ; v. 68, no. 4
    Description:
    Supplements: Post-licensure safety surveillance of recombinant zoster vaccine (Shingrix) —Vaccine Adverse Event Reporting System (VAERS), United States, October 2017–June 2018
    File Type:
    Filetype[PDF - 265.31 KB]
  3. Filetype[PDF - 349.78 KB]
    Published Date:
    February 28, 2019
    Source:
    MMWR. Morbidity and mortality weekly report ; v. 68, no. 4
    Description:
    Supplements: Post-licensure safety surveillance of recombinant zoster vaccine (Shingrix) —Vaccine Adverse Event Reporting System (VAERS), United States, October 2017–June 2018
    File Type:
    Filetype[PDF - 349.78 KB]
  4. Filetype[PDF - 466.12 KB]
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). United States. Food and Drug Administration..
    Published Date:
    12/17/03
    Description:
    The Vaccine Adverse Event Reporting System (VAERS) is a national program that monitors the safety of vaccines after they are licensed. VAERS is managed by the U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administra...
    File Type:
    Filetype[PDF - 466.12 KB]
  5. Filetype[PDF - 295.10 KB]
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). United States. Food and Drug Administration.. American Academy of Family Physicians.. American Academy of Pediatrics..
    Published Date:
    February 2013
    Description:
    • The Vaccine Adverse Event Reporting System (VAERS) is one component of the United States’ comprehensive vaccine safety monitoring system.• VAERS reports are monitored carefully by the Centers for Disease Control and Prevention (CDC) and the F...
    File Type:
    Filetype[PDF - 295.10 KB]